Standard Operating Procedure Disconnection of continuous infusional chemotherapy from Central Venous Access Devices (CVADs) in the Community
|
|
- Shavonne Stevenson
- 6 years ago
- Views:
Transcription
1 SH CP 192 Standard Operating Procedure Disconnection of continuous infusional chemotherapy from Central Venous Access Devices (CVADs) in the Community Version: 2 Summary: Keywords (minimum of 5): (To assist policy search engine) Target Audience: This Standard Operating Procedure states Southern Health Foundation Trust s position and expectation for all clinical teams with regards to the procedure for disconnection of continuous infusional chemotherapy for patients with CVADs chemotherapy, intravenous, cytotoxic drugs, disconnection, chemo, cyto All clinical teams who support patients Next Review Date: March 2021 Approved and ratified by: Patient Safety Group Date of meeting: 15 th February 2018 Date issued: Author: Sponsor: Steve Coopey Head of Clinical Development Juliet Wells Principal Pharmacist (North) Steve Mennear Medication Safety Officer Dr Abigail Barkham Integrated Services Matron Medical Director 1
2 Version Control Change Record Date Author Version Page Reason for Change April 16 J Wells 1 4 Summary flow chart added Aug 16 J Wells 1 To cover all kits as may vary with time 16/01/18 Reviewed no change Reviewers/contributors Name Position Version Reviewed & Date Dr Abigail Barkham Integrated Service Matron April 2015 Steve Coopey Head of Clinical Development June 2015, Aug 2016 Sue Hobbs Community Matron (Yew) April 2015 Juliet Wells Principal Pharmacist (North) June 2015, Aug 2016 Steve Mennear Medication Safety Officer June 2015, Aug 2016 Marie Corner Medical Device Adviser June 2015 Jacky Hunt Infection Control Nurse June 2015 Paula Deery Lead Chemotherapy Nurse (RSCH) June 2015 Jenny Nops Area Matron Winchester District and Enhanced Recovery +Support@Home January
3 Contents Section Title Page Quick reference guide 4 1 Purpose of this Standard Operating Procedure (SOP) 5 2 Glossary of Terms 5 3 Background 6 4 Expectations 6 5 Who can disconnect Infusors? 6 6 Training requirements 6 7 Supporting References 6 SOP Guidance and Rationale 8 A1 Risk Assessment 10 A2 Clinical Competencies for Chemotherapy Disconnection 12 Levels of competency Rating Scale for the disconnection of 14 chemotherapy (PICC or CVC) A3 Healthcare Waste Collection Referral Form s Contacts Table
4 Standard Operating Procedure Disconnection of continuous infusional chemotherapy from Central Venous Access Devices (CVADs) in the Community Secondary Care ICS Registered Nurse competent in Chemotherapy CVAD disconnection IV therapy trained + assessed in practice, using the Clinical Competencies for the disconnection of continuous infusional chemotherapy assessed by another competent nurse or if already competent by self-assessment Not IV trained; attend SHFT IV Therapy training day & assessment in practice Complete full risk assessment for disconnection of chemotherapy (appendix 1) Patient s Home Preparation Discuss process with patient Obtain patient s consent Wash Hands (SH CP 12) Put on PPE & gloves Aseptic Preparation Equipment PPE & Nitrile Gloves Purple lidded (cytotoxic) waste bin with absorbent layer Chemo spill kit 0.9% sodium chloride flush & administration equipment + a prescription or PGD 109 Risk Assessment (Appendix 1) Disconnection Check that all the drug is delivered Check that there is no leakage Clamp Remove Infusor & attach red bung Flush (PGD 109) Purple Cytotoxic Waste bin Put Infusor in purple bin Inform patient Arrange collection by secondary care or local council collection (Appendix 3) Dispose of PPE Double bag label Wash hands Document 4
5 Disconnection of continuous infusional chemotherapy from Central Venous Access Devices (CVADs) in the Community 1. Purpose of the Standard Operating Procedure (SOP) This SOP sets out a Trust wide statement and vision on how Southern Health NHS Foundation Trust (SHFT) plans to support the process for disconnection of continuous infusional chemotherapy for patients referred to SHFT community care. This document provides guidance to managers and teams on how SHFT expects staff to carry out this procedure safely. Clinical evidence demonstrates that a robust assessment is imperative in order to plan and execute an excellent standard and quality of care. Sufficient evidence exists indicating that staff that come into contact with cytotoxic drugs are at potential risk of harm. Therefore a robust SOP will assist the mitigation of risk and harm to both patients and SHFT staff. 2. Glossary of Terms Central Venous Catheter (CVC) An intravenous device that allows access to a vein for the purposes of administering medications, where the distal tip of the device/catheter sits in the lower third of the superior vena cava. PICC A Peripherally Inserted Central Catheter (PICC) is a form of intravenous (IV) access device that can be used for a designated prolonged period of time e.g. 46 hours, 4 days, or 7 days. Skin tunnelled catheter (STC) This central venous catheter is inserted in secondary care and is used for long term access for IV therapy. These can have an external clamp (Hickman catheter) or internal valve (Groshong PICCs). Each type has its own management guidelines for flushing solutions and frequency for flushing. Implanted Ports An implanted vascular access device placed under the skin, made of two components: a reservoir with a self-sealing septum which is attached to a silicone catheter. It is a central venous catheter licensed for long term use and becoming more commonly used in cancer chemotherapy settings Chemotherapy Infusor A closed system elastomeric device that administers cytotoxic medication over a set time to the patient via a PICC or other type of CVC. Referred to as infusors. PPE Kit. Personal Protective Equipment which is intended to be worn or held by healthcare workers to promote personal and patient safety (nitrile gloves, aprons and eye protection). Nurse Throughout this document the term nurse refers to practitioners who are currently registered with the Nursing and Midwifery (NMC). 5
6 3. Background Chemotherapy treatments and administration has significantly changed within the community resulting in increased need for staff working in this environment to understand the implications of these changes for their practice. Chemotherapy infusors are lightweight, portable, disposable elastomeric infusion devices that allow administration of chemotherapy as a continuous infusion over several days thus enabling patients to be treated at home rather than in hospital. The chemotherapy is contained in a balloon reservoir inside a casing. As batteries are not used in the device, it does not make any noise. Patients will have their infusors initiated in secondary care by oncology specialist services. Disconnection of these devices pumps often falls upon the services of SHFT staff and requires the procedure to be undertaken in patient s homes or community clinics. 4. Expectations SHFT expects all nurses to complete a comprehensive holistic assessment within 24 hours of patient admission to the Integrated Community Team. This will: Help patients to realise their concerns are worthy of consideration and not unusual. Open the door to discussion and bring attention to sources of help that may not be required immediately but maybe needed at some point later. Allow patients and carers to discuss their concerns or issues at an early stage Enable realistic goals to be set. Enable safe and effective discharge planning through effective well-being planning Ensure that a robust risk assessment is in place for patient and staff safety. Ensure that correct equipment is in place for the management of this procedure. Ensure that cytotoxic waste is disposed of safely. It is expected that all Nurses must be competent to complete the disconnection of chemotherapy from a CVAD. 5. Who can disconnect Infusors? Only Nurses in Integrated Community Services that have been trained in IV therapy and have successfully completed assessment of competence in practice. 6. Training requirements All Nurses must complete the single IV therapy training day and be assessed in practice as competent to undertake the disconnection of continuous infusional chemotherapy from a CVAD. If already competent in IV therapy, the Nurse must complete the self-assessment of Competency to disconnect a continuous infusional chemotherapy infusor or be assessed by another competent Nurse. The training records are to be kept on the staff member s LEAD training record. 7. Supporting references CQC (2009) Essential Standards of Quality and Safety, London, CQC HPC (2008)Standards of Conduct, Performance and Ethics 6
7 NMC (2015) The Code: Professional standards of practice ad behaviour for nurses and midwives London NMC NMC (2008) Standards for Medicines Management NPSA (2007) Promoting Safer Use of Injectable Medicines SHFT SH CP137 Intravenous Therapy and Cannulation Policy SHFT SH CP1 Medicines Control, Administration and Prescribing Policy SHFT SH NCP Handling and Disposal of Healthcare Waste Policy SHFT SH CP14 Sharps and inoculation Management SHFT SH CP 12 Hand Hygiene Procedure SHFT PGD 109 Sodium Chloride 0.9% Injection Herman GD, Kenyon RJ (1987) Competency-Based Vocational Education. A Case Study, Shaftsbury, FEU, Blackmore Press, cited in Fearon, M. (1998) Assessment and measurement of competence in practice, Nursing Standard 12(22), pp
8 STANDARD OPERATING PROCEDURE Disconnection of Continuous Infusional Title Chemotherapy from a Central Venous Access device in the Community There is sufficient evidence that staff who come into contact with cytotoxic medication are potentially at risk of harm. Expert review suggests that efforts should focus on ensuring correct procedure in handling such medication. Risks fall into the following categories; 1. Local effect caused by direct contact with skin, eyes, mucous membrane e.g. dermatitis. 2. The systematic effects of inhaling or ingesting cytotoxic drug during contact. 3. Effects on the unborn child if pregnant The safe procedures regarding intravenous access to the patients should also be adhered to. Action 1. Read care plan / support plan and check prescription details ensuring the right patient / patient is identified. Check the name, NHS number or date of birth, prescriber s signature, approved medicine name, dose and frequency of administration, rate, diluent, date and route of administration. 2. Ensure that a full risk assessment of environment & patient/family, and staff safety is completed, before carrying out the procedure (Appendix 1) 3. Ensure that the following equipment is available; PPE Nitrile Gloves Purple lidded sharps bin (cytotoxic sharps) with absorbent layer Chemotherapy Spillage Kit 0.9% sodium chloride (saline) Flush and equipment to administer Prescription/PGD109 to administer 0.9% sodium chloride injection. 4. Explain procedure to the patient and ask for and record verbal consent 5. Wash own hands with soap and water or clean with alcohol sanitising foam if hands socially clean as per Hand Hygiene Procedure SHCP12 Thendon PPE equipment: Plastic Apron, Nitrile Gloves, Eye Protection Rationale 1. Plan will explicitly identify care required. Chemotherapy disconnection should only be undertaken with the written directions of the secondary care provider through referral process. 2. This will ensure that the home environment is clean and calm for the task being undertaken. If not a more suitable community environment may be required to be sourced such as a clinic or community hospital. 3. To ensure that time is not wasted and procedure goes smoothly. To prevent infection. 4. To inform the patient and obtain evidence of informed consent. 5. To prevent cross infection and contamination from chemotherapy by following the Trust Infection Prevention and Control Policy and Hand Hygiene Procedure (SH CP 12) 6. Prepare the equipment for aseptic procedure 6. To minimise risk of infection 8
9 7. Before starting the disconnection procedure, ensure the complete delivery of the drug has occurred and there are no signs of leakage. If this is not the case contact initiating hospital centre for advice 8. Clamp off the infusor prior to disconnection 9. Remove the infusor from the CVAD. Attach the red bung to end of infusor line clamp and dispose of it in the designated purple lidded sharps bin provided from secondary care for collection by local council 10. Flush the CVAD with 0.9% sodium chloride injection 11. Ensure all PPE equipment is disposed of by placing in in a clinical waste bag. Only double bag if it has been contaminated by cytotoxic drugs and label clearly Cytotoxic Waste. Contact local council for collection (see Appendix 3. Clean hands. 7. To minimise risk of exposure to staff and patient. To ensure the patient has received their treatment. 8. To prevent the spillage of cytotoxic medication on removal. 9. Ensuring safe storage and disposal in that area 10. Ensuring correct care of the Intravenous Access Device according to Therapy and Peripheral Cannulation Policy SHCP Ensuring the safe disposal of waste potentially contaminated by cytotoxic drugs 12. Inform the patient to (a) return the waste bin back to secondary care, or (b) store safely until local collection. The bin will need to be sealed and labelled whilst awaiting disposal. 13. Record the details of the administration in the appropriate documentation 12. This will enable the waste to be disposed of and stored safely and that it is returned to the administering location or collected by the local 13. To prevent duplication of treatment and adherence to policy guidelines 9
10 APPENDIX 1 Risk Assessment for Disconnection of Chemotherapy from a CVAD A risk assessment must be fully completed by the Registered Nurse before the procedure of chemotherapy disconnection and line flushing is undertaken. If the answer is no to any of these questions an alternative strategy is required. Patient Name NHS Number D.O.B: 1 Patient Yes / No 1.1 An assessment and individualised care record has been completed by a registered practitioner. 1.2 The patient has no family or informal carers able to complete this procedure, who have had the appropriate training 1.3 The patient s physical condition requires the procedure to take place in the community 2 Registered Practitioner 2.1 The Registered Nurse (s) has completed training to undertake this role and has been assessed as competent. 2.2 Following training, the Registered Nurse accepts responsibility to perform the procedure of disconnecting continuous infusional chemotherapy from a CVAD management of a chemotherapy disconnection to the standard required by SHFT 2.3 Pregnant staff or those planning their pregnancy should be advised of the potential risk associated with handling chemotherapeutic/cytotoxic agents and given the opportunity to refrain from completing this task 3 Task Yes / No 3.1 Environmental risks have been identified, assessed, minimised and documented 3.2 The patient has been referred with required equipment and there is access to Personal Protective Equipment 3.3 There is an appropriate chemotherapy spill kit available 10
11 3.4 There are suitable storage facilities in the patient s home for securing waste including a purple-lidded sharps bin containing and absorbant to contain any cytotoxic liquid, which might leak from the device. 3.5 There are suitable disposal & collection facilities for medication waste (return to secondary care or collection) All aspects of the risk assessment have been completed and control measures achieved To be completed by Registered Nurse: Name Designation Signature Date 11
12 APPENDIX 2 - Clinical competencies for the Disconnection of Continuous Infusional Chemotherapy from a CVAD Name: Role: Base: Date initial intravenous therapy training completed: Date aseptic e-assessment completed: Competency Statement: The participant demonstrates clinical knowledge and skill in chemotherapy disconnection. Assessment in practice must be by a Registered Nurse who can demonstrate competence at level 4 or above. Performance criteria Assessment method Level achieved Date 1. Demonstrates safe knowledge in disconnecting IV chemotherapy. a) Identify the correct venous Questioning / access device appropriate for cytotoxic therapy. b) List three complications of Questioning / cytotoxic therapy c) Describe and demonstrate the precautions taken when handling cytotoxic medicines d) Demonstrate knowledge / practice on how to manage a cytotoxic spillage e) Describe and demonstrate precautions which should be taken by a pregnant or breast feeding woman in relation to cytotoxic therapy f) Demonstrate correct documentation following procedure/removal. Questioning / Questioning / Questioning / Questioning/ 2. Demonstrates safe practice in disconnecting chemotherapy a) Demonstrate safe knowledge Questioning / and practice of the equipment and preparation required for disconnection of chemotherapy including; patient preparation and comfort, and selection of correct equipment. b) Demonstrates knowledge and practice of safe removal of a chemotherapy infusor Assessment of patient and medical condition. Awareness of risks associated Questioning / Assessor 12
13 with removal. Appropriate use of PPE. Correct disposal of equipment. Ensuring patient comfort and safety. c) Demonstrate correct use of aseptic technique during the procedure, identifying key parts and key sites d) Demonstrate appropriate equipment preparation. e) Demonstrate correct removal technique f) Demonstrate correct disposal of waste and sharps. g) Demonstrate correct documentation following removal. Date all elements of Competency Tool completed Name Signature Status Date For Assessor I confirm that I have assessed the above named Registered Nurse and that he/she has demonstrated an overall competence in chemotherapy disconnection at level Assessor Signature Status Date Review Competent Registered Assessor Comments Dates: Yes / No Nurse Signature signature 13
14 Levels of competency Rating Scale for the disconnection of chemotherapy (PICC or CVC) Novice Level of achievement Cannot perform this activity satisfactorily to the level required in order to participate in the clinical environment Can perform this activity but not without constant supervision and assistance Can perform this activity with a basic understanding of theory and practice principles, but requires some supervision and assistance Level Competent Practitioner Can perform this activity with understanding of theory and practice principles without assistance and/or direct supervision Can perform this activity with understanding of theory and practice principles without assistance and/or direct supervision, at an appropriate pace and adhering to evidence based practice At this level competence will have been maintained for at least 6 months and/or is used frequently (2-3 times /week) The practitioner will demonstrate confidence and proficiency and show fluency and dexterity in practice This is the minimum level required to be able to assess practitioners as competent Can perform this activity with understanding of theory and practice principles without assistance and/or direct supervision, at an appropriate pace and adhering to evidence based practice. At this level the practitioner will be able to adapt knowledge and skill to special/ novel situations where there may be increased levels of complexity and/or risk Expert Can perform this activity with understanding of theory and practice principles without assistance and/or direct supervision, at an appropriate pace and adhering to evidence based practice. Demonstrate initiative and adaptability to special problem situations, and can lead others in performing this activity At this level the practitioner is able to co-ordinate, lead and assess others who are assessing competence. Ideally they will have a teaching and /or mentor qualification 6 Adapted from: Herman GD, Kenyon RJ (1987) Competency-Based Vocational Education. A Case Study, Shaftsbury, FEU, Blackmore Press, cited in Fearon, M. (1998) Assessment and measurement of competence in practice, Nursing Standard 12(22), pp
15 HEALTHCARE WASTE COLLECTION REFERRAL FORM APPENDIX 3 - Waste Management Sections to be completed by a Healthcare Professional Strictly Confidential PATIENT S DETAILS Patient s Name Patient s Address (Including Postcode) Patient s Telephone Number HEALTHCARE ASSESSMENT OF INTENDED WASTE RESULTING FROM TREATMENT Tick category YELLOW SHARPS BOX YELLOW SHARPS BOX PURPLE LID ORANGE SACK OFFENSIVE Infectious sharps contaminated with medicines Infectious sharps contaminated with cytotoxic / cytostatic products Infectious waste that can be treated Waste that is not infectious and does not require specialist treatment or disposal HEALTHCARE PROFESSIONAL DETAILS (To include Healthcare Professional; Name, contact number, address, fax or - stamp may be used) Declaration to be completed by PATIENT if PATIENT is submitting referral form to Local Authority Only waste as described above should be presented by the Patient under this referral Print Name Signature Date Once complete Healthcare Professional or Patient to send form to Local Authority collection service (details on reverse of form) 15
16 HEALTHCARE WASTE COLLECTION REFERRAL FORM Local Authority Reference Number Property type and Pick up location Additional information for Hampshire Local Authority use only Likely frequency and duration of requirement (e.g. weekly, on request) Sharps Box collection service (tick requirement) Deliver sharps box Collect and replace box Collect only no replacement Sack collection service (tick requirement) Deliver sacks Collect and replace sacks Collect only no replacement 16
17 HEALTHCARE WASTE COLLECTION REFERRAL FORM Local Authority Department Contact Postal Address Southampton City Eastleigh Borough New Forest District Test Valley Borough Business Support Direct Services Waste Management Clinical Waste Services Fax Number address Regulatory Services, Civic Centre, Southampton. SO14 7LY Hedge End Depot, Botley Road, Hedge End, Southampton, SO30 2RA Marsh Lane Depot, Marsh Lane, Lymington, Hampshire, SO41 9BX Unit 37 Macadam Way, West Portway, Andover, Hampshire, SP10 3XW Telephone Number Healthcare Professional use only Winchester City East Hampshire District Portsmouth City Havant Borough Gosport Borough Fareham Borough Basingstoke & Deane Borough Joint waste client team Waste Collection team Customer Services Administration team Administration team Joint waste client team East Hampshire District, Penns Place, Petersfield, GU31 4EX Street Environment, Portsmouth City, Civic Offices, Guildhall Square, Portsmouth, PO1 2NE Havant Borough, Southmoor Offices and Depot, 2 Penner Road, Havant, Hampshire, PO9 1QH healthcare.waste@havant.gcsx.gov.uk Streetscene, Community Customer service unit, Gosport Borough, Town Hall, High Street, Gosport, PO12 1EB Civic Offices, Civic Way, Fareham, PO16 1AZ Hart District, Civic Offices, Harlington Way, Fleet, Hampshire, GU51 4AE Please phone before use n/a healthcare.waste@gosport.gcsx.gov.uk healthcarewaste@fareham.gcsx.gov.uk clinical.waste@hart.gcsx.gov.uk Hart District Rushmoor Borough Contracts Team RBC Healthcare Waste, Offices, Farnborough Road, Farnborough, Hampshire, GU14 7JU Healthcare.waste@rushmoor.gcsx.gov.uk 17
Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework
Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Name: Location: Date commenced: Contents Competency: Page No: Page 1. Core: Introduction Demonstrate knowledge that
More informationAdministration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure
Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Quality and Standards Group Date
More informationCentral Venous Access Devices (CVAD) Procedures
SH CP 138 Central Venous Access Devices (CVAD) Procedures (e.g. Peripherally Inserted Central Catheter ( PICC lines) and Skin Tunnelled Central lines) Version:2 Summary: Keywords (minimum of 5): (To assist
More informationDepartment Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual
Department Policy Code: D: MM-5615 Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Chemotherapy Purpose: Ensure
More informationMedication Administration Using the Home Pump (Eclipse)
Medication Administration Using the Home Pump (Eclipse) Phone Number: Nurse/Contact: Receiving IV Therapy in the Home Your doctor has ordered for you to receive your IV medication at home. Receiving IV
More informationGuidelines for undertaking a bladder scan for the purpose of identifying residual urine
SH CP 155 Guidelines for undertaking a bladder scan for the purpose of identifying residual urine Summary: Keywords (minimum of 5): (To assist policy search engine) Target Audience: These guidelines are
More informationPolicies and Procedures. RNSP: RN Procedure. I.D. Number: 1067
Policies and Procedures RNSP: RN Procedure Title: CHEMOTHERAPY BLADDER INSTILLATION (INTRAVESICAL) CARE OF CLIENT I.D. Number: 1067 Authorization: [] SHR Nursing Practice Committee Source: Nursing Date
More informationENDORSED BY THE GOVERNANCE COMMITTEE
Guideline for Expectant Mothers and those trying to conceive involved in the administration of and/or the care of patients receiving chemotherapy/monoclonal antibodies Version History Version Date Brief
More informationHealth & Social Services
The States of Jersey Department for Health & Social Services AGREED PROCESS FOR COMMUNITY INTRAVENOUS THERAPY Date approved DOCUMENT PROFILE Document Registration Document Purpose Short Title Author Publication
More informationChemotherapy Practice Competencies. To be used in conjunction with Teesside University module:
Chemotherapy Practice Competencies To be used in conjunction with Teesside University module: AHH3088-N - Chemotherapy Enhancing Practice in Cancer Care School of Health & Social Care NAME. PLACE OF WORK
More informationPOLICY FOR TAKING BLOOD CULTURES
Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)
More informationSOP Venesection Registered Nurses
HAEM / ONC WARD & DAY UNIT STANDARD OPERATING PROCEDURE SOP Venesection Registered Nurses Document Code Version Number 1 Issue Number 1 Date of Issue 07/03/2014 Review Interval 2 years Author (original
More informationIntravenous Medication Administration via a Central Venous Line
Standard Operating Procedure 11 (SOP 11) Intravenous Medication Administration via a Central Venous Line Why we have a procedure? This procedure is to assist/ inform healthcare professionals on how to
More informationChildren s Community Nursing Team Chemotherapy Policy
Children s Community Nursing Team Chemotherapy Policy 1 Policy : Children s Community Nursing Team Chemotherapy Policy Executive Summary The purpose of this document is to set out guidance for the safe
More informationASEPTIC TECHNIQUE LEARNING PACKAGE
ASEPTIC TECHNIQUE LEARNING PACKAGE Staff Name:... Date:... Table of Contents What is Aseptic technique? 3 Core infection control components 3 Key parts 5 References 6 Aseptic technique questionnaire 7
More informationPatient Self Administration of Intravenous (IV) Antibiotics at Home
Trust Policy Document Ref. No: PP(16)319 Patient Self Administration of Intravenous (IV) Antibiotics at Home For use in: For use by: For use for: Document owner: Status: Clinical Areas Clinical Staff Patient
More informationDISTRICT NURSING and INTERMEDIATE CARE
CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above
More informationAdministration of urinary catheter maintenance solution by a carer
Document level: Trustwide Code: CP71 Issue number: 1 Administration of urinary catheter maintenance solution by a carer Lead executive Director of Nursing Therapies Patient Partnership Authors details
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationIntravenous Therapy and Peripheral Cannulation Policy
SH CP 137 Intravenous Therapy and Peripheral Cannulation Policy Version 3 Summary: Keywords: Target Audience: To enable patients on intravenous therapy to continue or complete treatment within the primary
More informationThis guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.
CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing
More informationPOLICY FOR ASEPTIC TECHNIQUE AND ASEPTIC NON TOUCH TECHNIQUE
POLICY FOR ASEPTIC TECHNIQUE AND ASEPTIC NON TOUCH TECHNIQUE Please be aware that this printed version of the Policy may NOT be the latest version. Staff are reminded that they should always refer to the
More informationSELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING
CLINICAL PROTOCOL SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING RATIONALE Medication errors can cause unnecessary
More informationASEPTIC TECHNIQUE POLICY
SECTION 3b ASEPTIC TECHNIQUE POLICY INFECTION CONTROL MANUAL Read in conjunction with: o Hand hygiene policy (also section 3) o Standard (Universal) Precautions policy (section 4) o Decontamination policy
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:
More information21 st Century Health Care Consultants
21 st Century Health Care Consultants Presents 1 Investing in your Infusion Specialty Program Presented by: Rhonda Surgnier RN Becky Tolson RN David Kachel CRNI INFUSION THERAPY OBJECTIVES 2 At the completion
More informationProtocol for the Safe Administration of Intrathecal and Intraventricular Chemotherapy
Protocol for the Safe Administration of Intrathecal and Intraventricular Chemotherapy Version Number 18 Contact details: Debra Robertson, Lead Oncology Pharmacist, Pharmacy, Salisbury District Hospital
More informationRisk Assessment Form HS 9 (1)
s Full Name: Date of Birth: NHS Number 1. The fully implanted port system Sitimplant is not regularly used in the community and nursing staff may be unfamiliar with the recommended care of this system
More informationHealthcare Associated Infection (HAI) inspection tool
Healthcare Associated Infection (HAI) inspection tool Hospital: Ward/Department: Inspector: Date: Guidance note: This tool is designed to assist HEI inspectors assess NHS boards compliance with NHS Quality
More informationPolicy for Handling the Spillage of Cytotoxic and Anti-Cancer Drugs
Policy for Handling the Spillage of Cytotoxic and Anti-Cancer Drugs Department / Service: Pharmacy Originator: Stephanie Cook Accountable Director: Nick Hubbard Approved by: Medicines safety committee
More informationFOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING
STANDARD OPERATING PROCEDURE FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective medicine administration
More informationCommunity Infection Prevention and Control Guidance for Health and Social Care. Waste Management
Community Infection Prevention and Control Guidance for Health and Social Care Waste Management Version 1.01 May 2015 Harrogate and District NHS Foundation Trust Waste Management May 2015 Version 1.01
More informationProcedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG
Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG Introduction All health and social care organisations are accountable for ensuring the safe management of controlled drugs
More informationAdministration of Intravenous Medication by Adults & Children s Services in the Community Setting and Adult Bed Based Units Policy
High Value Health Care Administration of Intravenous Medication by Adults & Children s Services in the Community Setting and Adult Bed Based Units Policy (Reference No. CP53 8016) Version: Version 5, July
More informationCommunity Intravenous Therapy Referral Standards
pecialist harmacy ervice Medicines Use and afety Community Intravenous Therapy Referral tandards Background A multi-centred audit of prescribing and administration of community IV therapy across East and
More informationNBCP PO C Administration of injections
POLICY CATEGORY: POLICY FOCUS: POLICY NAME: Administration of injections policy (EN) LAST UPDATED: February 2014 MOTION NUMBER: C-14-02-08 OTHER: GM-PP-I-03 (Supplement to administration of injections
More informationLincolnshire Partnership NHS Foundation Trust (LPFT) Title of Policy
Lincolnshire Partnership NHS Foundation Trust (LPFT) Title of Policy REF: 7n DOCUMENT VERSION CONTROL Document Type and Title: Correct Use of Personal Protective Environment Authorised Document Folder:
More informationSetting up and running a community IV therapy clinic
Setting up and running a community IV therapy clinic Moving care to the community has been a UK-wide health and social care priority for more than a decade (Royal College of Nursing [RCN], 2013). With
More informationInfection Control Safety Guidance Document
Infection Control Safety Guidance Document Lead Directorate and Service: Corporate Resources - Human Resources, Safety Services Effective Date: June 2014 Contact Officer/Number Garry Smith / 01482 391110
More informationChemotherapy Training and Assessment Framework for Registered Nurses
Chemotherapy Training and Assessment Framework for Registered Nurses Document Control Prepared By Issue Date Approved By Review Date Version Contributors Comments/ Amendment Jane Beveridge January 2012
More informationVascuport in Children for Routine Flushing and Administration of Medication
Standard Operating Procedure 6 (SOP 6) Vascuport in Children for Routine Flushing and Administration of Medication Why we have a procedure? This guidance is to assist/ inform healthcare professionals on
More informationNUH Medicines Policy: Code of Practice. NUH Intravenous Drug Administration Policy
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST NUH Medicines Policy: Code of Practice Reference CL/MM/036 Approving Body Directors Group Date Approved 5 Implementation Date 5 Summary of n/a Changes from Previous
More informationSAFE HANDLING OF HAZARDOUS MEDICATIONS (CYTOTOXIC AND NON-CYTOTOXIC) POLICY
SAFE HANDLING OF HAZARDOUS MEDICATIONS (CYTOTOXIC AND NON-CYTOTOXIC) POLICY POLICY # 110.160.010 NEWLY REVISED: OCTOBER 2015 AVAILABLE AT: HTTP://HOME.WRHA.MB.CA/PROG/MEDQUALITY/POLICIES.PHP Safe Handling
More informationADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS
ADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS This policy should be read in conjunction with the Syringe Driver Policy and the Medicines Policy Version: 6 Date of Issue:
More informationCentral Venous Access Devices (CVADs) Hickman/Broviac and PICC Care Management Policy
Central Venous Access Devices (CVADs) Hickman/Broviac and PICC Care Management Policy (Note: See Separate Policy for Port-a-Cath Care and Management) DOCUMENT CONTROL: Version: v2 Ratified by: Quality
More informationSTANDARD PRECAUTIONS POLICY Page 1 of 8 Reviewed: May 2017
Page 1 of 8 Policy Applies to: All Mercy Staff, Credentialed Specialists, Allied Health Professionals, students, patients, visitors and contractors will be supported to meet policy requirements Related
More informationVersion: 5 Date Issued: 24 October 2017 Review Date: 24 October 2020 Document Type: Policy. Sharps Safety Policy Quick Reference Guide
Sharps Safety Policy Version: 5 Date Issued: 24 October 2017 Review Date: 24 October 2020 Document Type: Policy Contents Page Paragraph Executive Summary 2 1 Introduction 3 2 Scope 3 3 Purpose 3-4 4 Definitions
More informationSelf-Administration Guidelines
SH CP 168 Self-Administration Guidelines Summary: Keywords (minimum of 5): (To assist policy search engine) Target Audience: Procedure for when a patient takes responsibility for taking own medicines as
More informationHomeMed Information. for the UMHS Cancer Center
HomeMed Information for the UMHS Cancer Center 1 In this manual you will find the following information: Your Health Care Team... HomeMed... 3 When to notify your team or HomeMed... 4 Infusion Pump Guide
More informationSELF ADMINISTRATION OF MEDICATIONS PROGRAMME FOR REHABILITATION & RECOVERY SERVICES AND LOW/MEDIUM SECURE SERVICES
MENTAL HEALTH DIRECTORATE POLICY SELF ADMINISTRATION OF MEDICATIONS PROGRAMME FOR REHABILITATION & RECOVERY SERVICES AND LOW/MEDIUM SECURE SERVICES Originator: Mental Health Policies and Procedures Group
More informationPOLICY ON THE HANDLING OF CHEMOTHERAPY BY STAFF WHO ARE PREGNANT OR BREASTFEEDING
Policy on the handling of chemotherapy by staff who are pregnant/breastfeeding, v2.1 POLICY ON THE HANDLING OF CHEMOTHERAPY BY STAFF WHO ARE PREGNANT OR BREASTFEEDING Version: 2.1 Ratified by: Date ratified:
More informationCENTRAL VENOUS ACCESS DEVICE POLICY
CENTRAL VENOUS ACCESS DEVICE POLICY Version: 1 Date of Issue: April 2018 Review Date: April 2021 Applies to: All clinical staff who care for patients with Central Venous Access Devices (CVADs) as part
More informationInfection Prevention Control Team
Title Document Type Document Number Version Number Approved by Infection Control Manual Section 3.1 Isolation Precautions and Infection Control Care Plan Policy 3 rd Edition Infection Control Committee
More informationSharps Safety Policy
Sharps Safety Policy Version Number 3.1 Version Date March 2016 Guideline Owner Author Staff/Groups Consulted Discussed by Infection Prevention and Control Committee Approved by Infection Prevention and
More information1. Infection Control, Centers for Disease Control and Prevention (CDC). (2002). Guideline for hand hygiene in health-care settings
HOSPITAL CORPSMAN SKILLS BASIC (HMSB) MAY 8 Checklist (PCL) Clinical Skill: Intravenous Therapy Circle One: Initial Evaluation Re-Evaluation Command: A. INTRODUCTION Upon successful completion of this
More informationAMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy
AMPH-PGN-10 Practice Guidance Note Intramuscular Injection (IMI) V01 Date Issued Planned Review PGN No: Issue 1 Sep 2017 Sep 2020 AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and
More informationBloodborne Pathogens Cumru Township Fire Department 02/10/2011 Policy 10.5 Page: 1 of 7
Policy 10.5 Page: 1 of 7 Purpose: The Cumru Township Fire Department is committed to providing a safe and healthful work environment for our entire staff, both career and volunteers. In pursuit of this
More informationAdministration of Chemotherapeutic Agents
Administration of Chemotherapeutic Agents Contributed by The Outer Banks Hospital Nags Head, NC Leading Practices Library Organizations submit practices to The Joint Commission that they have found to
More informationLimitations and Guidelines Revised for Elastomeric Devices and IV Supplies and Equipment
Limitations and Guidelines Revised for Elastomeric Devices and IV Supplies and Equipment Information posted January 8, 2007 Effective for dates of service on or after March 1, 2007, benefit limitations
More informationPROCEDURE FOR THE MANAGEMENT OF BODY WASTE AND CLINICAL SAMPLES FROM PATIENTS RECEIVING CYTOTOXIC DRUGS
Procedure for the management of body waste & clinical samples from patients receiving cytotoxic drugs, v2.1.0 PROCEDURE FOR THE MANAGEMENT OF BODY WASTE AND CLINICAL SAMPLES FROM PATIENTS RECEIVING CYTOTOXIC
More informationAgency workers' Personal Hygiene and Fitness for Work
Policy 17 Infection Control A24 Group recognises its duty to promote a safe working environment for domiciliary care workers and clients. The control of infectious diseases is an important aspect of this
More informationMARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa
MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa CARE OF PATIENT POLICY & PROCEDURES Policy Number: 4.37 Subject: Implanted Venous Access Device (Infus-A-Port), Nursing Management Of (Indwelling
More informationInfection Control Care Plan for a patient with Group A Streptococcus
Infection Control Care Plan for a patient with Group A Streptococcus Statement: This Care Plan should be used with patients who are suspected of or are known to have Group A Streptococcal infection. This
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationPeripherally Inserted Central Catheter
UW MEDICINE PATIENT EDUCATION Peripherally Inserted Central Catheter Understanding your PICC procedure and consent form Please read this handout before reading and signing the form Special Consent for
More informationCentral Venous Access Devices (CVADs)
Contents Purpose... 1 Policy... 1 Scope... 2 Associated documents... 2 1 Insertion of CVADs... 2 2 Endorsement/Certification... 2 3 Procedural Considerations... 3 3.1 Checking and Identification requirements...
More informationHow to use your Mitomycin C eye drops % or 0.02%
How to use your Mitomycin C eye drops - 0.04% or 0.02% Information for patients Ocular Oncology Clinic Large Print page 2 of 8 You have been prescribed these eye drops to treat your eye condition. Mitomycin
More informationDerby Hospitals NHS Foundation Trust. Drug Assessment
Drug Assessment for Preparation and Administration of Oral, Enteral, Ophthalmic, Topical, PR, PV, Inhaled, Subcutaneous and Intramuscular Medicines to Patients (N.B. The preparation and administration
More informationGuidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings
Guidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings : Program Goal Improve personnel safety in the healthcare environment through appropriate use of PPE. :
More informationPRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0
PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline
More informationHome+ Home+ Home Infusion. Home Infusion. regionalhealth.org/home
Department of Regional Health Rapid City Hospital 224 Elk Street, Suite #100 Rapid City, SD 57701 605-755-1150 Toll Free 844-280-9638 Fax 605-755-1151 regionalhealth.org/home 20160810_0917 Regional Health
More informationBLOODBORNE PATHOGENS EXPOSURE PREVENTION POLICY AND PROCEDURE BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN
BLOODBORNE PATHOGENS EXPOSURE PREVENTION POLICY AND PROCEDURE This sample plan is provided only as a guide to assist in complying with the OSHA Bloodborne Pathogens standard 29 CFR 1910.1030, as adopted
More informationStandard Precautions for Infection Control
Standard Precautions for Infection Control Author(s) & Designation Lead Clinician if appropriate In consultation with To be read in association with Ratified by Suzanne Golding-Ellis, Head of Patient Safety
More informationAdministering Cytarabine to Children in the Community Setting
Standard Operating Procedure 18 (SOP 18) Administering Cytarabine to Children in the Community Setting Why we have a procedure? Cytarabine is a chemotherapy drug which is prescribed for some children as
More informationYou and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath Nursing A guide for patients and carers Contents What is a TIVAD?... 1 Why is a TIVAD necessary?... 2 How a TIVAD is inserted...
More informationCORPORATE SAFETY MANUAL
CORPORATE SAFETY MANUAL Procedure No. 27-0 Revision: Date: May 2005 Total Pages: 9 PURPOSE To make certain that our employees are duly aware of the hazards of blood exposure or other potentially infectious
More informationEAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY
EAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY Department: Neurology (Hemby Lane) Date Originated: 2/20/14 Date Reviewed: 6.5.18 Date Approved: 6/3/14 Page 1 of 7 Approved by: Department Chairman Administrator/Manager
More informationSystemic anti-cancer therapy Care Pathway
Network Guidance Document Status: Expiry Date: Version Number: Publication Date: Final July 2013 V2 July 2011 Page 1 of 9 Contents Contents... 2 STANDARDS FOR PREPARATION AND PHARMACY... 3 1.1 Facilities
More informationCAPE ELIZABETH SCHOOL DEPARTMENT Cape Elizabeth, Maine
In accordance with OSHA Bloodborne Pathogens standards, 29 CFR 1910.1030, the following exposure control plan has been developed. 1. EXPOSURE DETERMINATION The purpose of this plan is to limit occupational
More informationVersion: 5. Date Adopted: 17 April Date issued for publication: Review date: October Expiry date: 1 April 2021
The Policy and Procedure for the Administration of Intravenous Medication to Adults and Children within the Community and Community Hospital The document prescribes how clinicians will administer medication
More informationHAZARDOUS DRUGS: HANDLING PRECAUTIONS BACKGROUND PURPOSE POLICY STATEMENTS
BACKGROUND Hazardous drugs are drugs that pose a potential health risk to workers who may be exposed to them during receipt, transport, preparation, administration, or disposal. These drugs require special
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationHouston Controls, Inc Safety Management System
Preparation: Safety Mgr Authority: Dennis Johnston Issuing Dept: Safety Page: Page 1 of 8 Purpose This Bloodborne Pathogen Exposure Control Plan has been established to ensure a safe and healthful working
More informationMSAD 55. Blood Borne Pathogens Control Plan. 137 South Hiram Road Hiram, Maine (207)
MSAD 55 Blood Borne Pathogens Control Plan 137 South Hiram Road Hiram, Maine 04041 www.sad55.org (207) 625-2490 MSAD 55 BLOOD BORNE PATHOGENS EXPOSURE CONTROL PLAN 1 PURPOSE In accordance with the OSHA
More informationIMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE
Art & science The acute district synthesis care nursing of art and science is lived by the nurse in the nursing act JOSEPHINE G PATERSON IMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE
More informationSARASOTA MEMORIAL HOSPITAL STANDARDS OF CARE STANDARDS OF PRACTICE DEPARTMENT OF IV THERAPY (IV THERAPISTS)
UNIT: SARASOTA MEMORIAL HOSPITAL STANDARDS OF CARE STANDARDS OF PRACTICE DEPARTMENT OF IV THERAPY (IV THERAPISTS) STANDARD #: EFFECTIVE DATE: REVISED DATE: STANDARD TYPE: 04/91 5/05, 3/08 DEPARTMENTAL
More informationIsolation Care of Patients in Isolation due to Infection or Disease
Infection Prevention and Control Assurance - Standard Operating Procedure 6 (IPC SOP 6) Isolation Care of Patients in Isolation due to Infection or Disease Why we have a procedure? The spread of infection
More informationBlood Culture Policy
Policy No: IC27 Version: 5.0 Name of Policy: Blood Culture Policy Effective From: 21/09/2015 Date Ratified 15/09/2015 Ratified Infection Prevention and Control Committee Review Date 01/09/2017 Sponsor
More informationPreventing Infection in Care
Infection Prevention and Control: Older Person Care Homes & Home Environment Learning Programme Workbook NHS Education for Scotland 2011. You can copy or reproduce the information in this document for
More informationKING S HOUSE SCHOOL FIRST AID & MEDICINES AND MEDICAL CONDITIONS MANAGEMENT POLICY
Member of staff responsible : School Nurse Date of policy review : June 2018 Date of next review : June 2020 Approved by Governors : June 2018 KING S HOUSE SCHOOL FIRST AID & MEDICINES AND MEDICAL CONDITIONS
More informationInfection Control Policy
Infection Control Policy Category Summary Policy This policy outlines BAPAM s principles and procedures for infection prevention and control in the clinics environment. It is applicable to all BAPAM personnel
More informationHAZARDOUS SUBSTANCES POLICY Page 1 of 5 Reviewed: May 2017
Page 1 of 5 Policy Applies to: All staff employed by Mercy, Credentialed Specialists, Allied Health Professionals and contractors Related Standards: Health and Safety At Work Act, 2015 Hazardous Substances
More informationCENTRAL IOWA HEALTHCARE Marshalltown, Iowa
CENTRAL IOWA HEALTHCARE Marshalltown, Iowa CARE OF PATIENT POLICY & PROCEDURES Policy Number: 4.37 Subject: Implanted Venous Access Device (Infus-A-Port), Nursing Management Of (Indwelling Vascular Access
More informationNURSE-LED DISCHARGE POLICY
THE NORTH WEST LONDON HOSPITALS TRUST Name: NURSE-LED DISCHARGE POLICY Communication 1. All staff must be aware of this policy. 2. All first line managers must have read and have a working knowledge of
More informationThe School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT
The School Of Nursing And Midwifery. BMedSci Nursing (Adult) CLINICAL SKILLS PASSPORT Student Details NAME: COHORT: I understand that this booklet may be reviewed by my mentor, the programme leader, my
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationInjectable Medicines Policy. (Prescribing, Preparing and Administering Injectable Medicines Policy)
Document Control Title Injectable Medicines Policy (Prescribing, Preparing and Administering Injectable Medicines Policy) Authors Directorate Trustwide Date Version Issued 0.1 May 2013 1.0 July 2013 1.1
More informationPolicy for Non-Medical Prescribing
SH CP 179 Summary: Keywords (minimum of 5): (To assist policy search engine) This policy sets out the standards for Non-Medical Prescribing within Southern Health NHS Foundation NHS Trust. It will ensure
More informationCONTINENCE POLICY EYFS
CONTINENCE POLICY EYFS Date Published: March 2017 Introduction Children of all ages may experience continence issues often related to their age or stage of development; for some children incontinence may
More informationHealth and Safety Performance Standard HSPS 004 Body Fluid Spillages
Health and Safety Performance Standard HSPS 004 Body Fluid Spillages HSPS.004/Safety, Health and Environment Unit/SCM/27.09.04 1 Safety, Health and Environment Unit Title Reference Number Body Fluid Spillages
More information